- SRAX recently provided the market with its 2022 revenue forecast, guiding of $46-48 million in top-line revenues which surpassed street estimates of $42.52 million
- The company also seized upon the opportunity to update investors on their preferred shares, each of which would be eligible for a cash payment of $0.01, payable in January 2022
- Simultaneously, SRAX also revealed that they had repurchased 155,000 common shares over the last quarter as part of their enhanced shareholder returns initiative
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, recently updated the market on its guidance for the upcoming financial year as well revealing details on its ongoing shareholder payout schedule.
SRAX guided that the company was forecasting revenues of $11.5 million for the first quarter of 2022, with full year revenues of $46-48 million. The numbers follow a strong series of recent results, with SRAX reporting $8.3 million in…
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
